Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2011

01-02-2011 | Letter to the Editor

Methicillin-resistant Staphylococcus-aureus-associated glomerulonephritis on the decline: decreased incidence since the 1990s

Authors: Joichi Usui, Masaki Kobayashi, Itaru Ebihara, Akio Koyama, Kunihiro Yamagata

Published in: Clinical and Experimental Nephrology | Issue 1/2011

Login to get access

Abstract

We believe that bacterial-infection-associated glomerulonephritis (GN), so-called methicillin-resistant Staphylococcus aureus (MRSA)-GN, was exterminated in Japan. The control of bacterial infection is the most important part of infection-associated GN. In 1990s Japan, hospital-associated MRSA (HA-MRSA) caused MRSA-GN outbreaks. On the other hand, MRSA-GN incidence has been quite limited since 2000. This epidemiological transition suggests that antibacterial therapies and health programs for HA-MRSA infection in Japan were effective against MRSA-GN. Moreover, it appears that staphylococcal superantigens act in the pathogenesis of GN. The change of superantigen production might have influenced to the disappearance of MRSA-GN. If HA-MRSA-producing superantigen outbreaks occur in developing countries, our experience in Japan can provide guiding principles for preventing and eradicating GN.
Literature
1.
go back to reference Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, et al. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 1995;47:207–16.CrossRefPubMed Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, et al. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 1995;47:207–16.CrossRefPubMed
2.
go back to reference Denton MD, Digumarthy SR, Chua S, Colvin RB. Case 20–2006: an 84-year-old man with staphylococcal bacteremia and renal failure. N Engl J Med. 2006;354:2803–13.CrossRefPubMed Denton MD, Digumarthy SR, Chua S, Colvin RB. Case 20–2006: an 84-year-old man with staphylococcal bacteremia and renal failure. N Engl J Med. 2006;354:2803–13.CrossRefPubMed
3.
go back to reference Satoskar AA, Nadasdy GN, Plaza JA, Sedmak D, Shidham G, Hebert L, et al. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol. 2006;1:1179–86.CrossRefPubMed Satoskar AA, Nadasdy GN, Plaza JA, Sedmak D, Shidham G, Hebert L, et al. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol. 2006;1:1179–86.CrossRefPubMed
4.
go back to reference Haas M, Racusen LC, Bagnasco SM. IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features. Hum Pathol. 2008;39:1309–16.CrossRefPubMed Haas M, Racusen LC, Bagnasco SM. IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features. Hum Pathol. 2008;39:1309–16.CrossRefPubMed
5.
go back to reference Nachman PH, Jennette JC, Falk RJ. Primary glomerular disease (Acute post-streptococcal glomerulonephritis (PSGN)). In: Brenner BM, editor. Brenner & Rector’s the kidney. 8th ed. Philadelphia: WB Saunders; 2008. p. 1019–24. Nachman PH, Jennette JC, Falk RJ. Primary glomerular disease (Acute post-streptococcal glomerulonephritis (PSGN)). In: Brenner BM, editor. Brenner & Rector’s the kidney. 8th ed. Philadelphia: WB Saunders; 2008. p. 1019–24.
6.
go back to reference Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, et al. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J Antimicrob Chemother. 2007;59:1148–54.CrossRefPubMed Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, et al. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J Antimicrob Chemother. 2007;59:1148–54.CrossRefPubMed
7.
go back to reference Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med. 2010;170:552–9.CrossRefPubMed Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, et al. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med. 2010;170:552–9.CrossRefPubMed
8.
go back to reference Yamamoto T, Nishiyama A, Takano T, Yabe S, Higuchi W, Razvina O, et al. Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance. J Infect Chemother. 2010;16(4):225–54.CrossRefPubMed Yamamoto T, Nishiyama A, Takano T, Yabe S, Higuchi W, Razvina O, et al. Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance. J Infect Chemother. 2010;16(4):225–54.CrossRefPubMed
9.
go back to reference Tanaka T, Okuzumi K, Iwamoto A, Hiramatsu K. A retrospective study of methicillin-resistant Staphylococcus aureus clinical strains in Tokyo University Hospital. J Infect Chemother. 1995;1:40–9.CrossRef Tanaka T, Okuzumi K, Iwamoto A, Hiramatsu K. A retrospective study of methicillin-resistant Staphylococcus aureus clinical strains in Tokyo University Hospital. J Infect Chemother. 1995;1:40–9.CrossRef
10.
go back to reference Higashiyama M, Ito T, Han X, Ono K, Minamimura K, Sakakibara F, et al. Epidural abscess caused by community-associated methicillin-resistant Staphylococcus aureus strain USA300 in Japan. J Infect Chemother. 2010;16(5):345–9.CrossRefPubMed Higashiyama M, Ito T, Han X, Ono K, Minamimura K, Sakakibara F, et al. Epidural abscess caused by community-associated methicillin-resistant Staphylococcus aureus strain USA300 in Japan. J Infect Chemother. 2010;16(5):345–9.CrossRefPubMed
11.
go back to reference DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet. 2010;375:1557–68.CrossRefPubMed DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet. 2010;375:1557–68.CrossRefPubMed
12.
go back to reference Tristan A, Ferry T, Durand G, Dauwalder O, Bes M, Lina G, et al. Virulence determinants in community and hospital methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2007;65:105–9.CrossRefPubMed Tristan A, Ferry T, Durand G, Dauwalder O, Bes M, Lina G, et al. Virulence determinants in community and hospital methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2007;65:105–9.CrossRefPubMed
13.
go back to reference Kramer A, Wagenvoort H, Ahren C, Daniels-Haardt I, Hartemann P, Kobayashi H, et al. Epidemiology of MRSA and current strategies in Europe and Japan. GMS Krankenhaushygiene interdisziplinar. 2010;5:1–10.CrossRef Kramer A, Wagenvoort H, Ahren C, Daniels-Haardt I, Hartemann P, Kobayashi H, et al. Epidemiology of MRSA and current strategies in Europe and Japan. GMS Krankenhaushygiene interdisziplinar. 2010;5:1–10.CrossRef
Metadata
Title
Methicillin-resistant Staphylococcus-aureus-associated glomerulonephritis on the decline: decreased incidence since the 1990s
Authors
Joichi Usui
Masaki Kobayashi
Itaru Ebihara
Akio Koyama
Kunihiro Yamagata
Publication date
01-02-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0369-x

Other articles of this Issue 1/2011

Clinical and Experimental Nephrology 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.